Transcat, Inc. (NASDAQ:TRNS) CEO Lee D. Rudow Sells 2,373 Shares

Transcat, Inc. (NASDAQ:TRNS) CEO Lee D. Rudow sold 2,373 shares of the stock in a transaction dated Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the sale, the chief executive officer now directly owns 103,688 shares in the company, valued at approximately $11,553,953.84. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Transcat Price Performance

Shares of TRNS opened at $107.62 on Thursday. The company’s fifty day simple moving average is $108.31 and its 200 day simple moving average is $101.32. The company has a market cap of $950.28 million, a price-to-earnings ratio of 82.79 and a beta of 0.59. Transcat, Inc. has a 1-year low of $74.89 and a 1-year high of $115.41. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $65.17 million during the quarter, compared to the consensus estimate of $63.36 million. Transcat had a return on equity of 9.32% and a net margin of 4.16%. On average, research analysts forecast that Transcat, Inc. will post 1.36 earnings per share for the current fiscal year.

Institutional Trading of Transcat

Several institutional investors have recently added to or reduced their stakes in the stock. Wasatch Advisors LP boosted its holdings in shares of Transcat by 13.3% during the 4th quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock worth $76,651,000 after buying an additional 82,458 shares in the last quarter. Broadcrest Asset Management LLC lifted its holdings in shares of Transcat by 17.6% in the 4th quarter. Broadcrest Asset Management LLC now owns 400,000 shares of the scientific and technical instruments company’s stock worth $43,732,000 after purchasing an additional 60,000 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of Transcat by 184.9% in the 1st quarter. Bank of America Corp DE now owns 83,687 shares of the scientific and technical instruments company’s stock worth $6,790,000 after purchasing an additional 54,314 shares in the last quarter. Comerica Bank bought a new position in shares of Transcat in the 3rd quarter worth $5,221,000. Finally, Vanguard Group Inc. lifted its holdings in shares of Transcat by 12.3% in the 4th quarter. Vanguard Group Inc. now owns 477,799 shares of the scientific and technical instruments company’s stock worth $52,238,000 after purchasing an additional 52,421 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. HC Wainwright increased their price objective on shares of Transcat from $108.00 to $124.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. TheStreet raised shares of Transcat from a “c+” rating to a “b” rating in a research note on Wednesday, January 31st.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.